These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14988706)

  • 1. Iatrogenic ulceration of melanoma is not of prognostic significance.
    Helm TN
    J Am Acad Dermatol; 2004 Mar; 50(3):487; author reply 487-8. PubMed ID: 14988706
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
    Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of detecting sex hormone receptors for the treatment and prognostic assessment of malignant melanoma].
    Wehner F; Wohlrab W
    Dermatol Monatsschr; 1989; 175(9):541-7. PubMed ID: 2684695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients.
    Shaw HM; Scolyer RA; Thompson JF
    Histopathology; 2008 Jan; 52(2):242; author reply 242-4. PubMed ID: 18184275
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
    Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
    Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsy methods for melanoma.
    Tomsick RS
    Cutis; 1983 May; 31(5):498, 514. PubMed ID: 6851646
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biopsy in suspected melanoma?].
    Lischka G
    Dtsch Med Wochenschr; 1973 Jun; 98(24):1239. PubMed ID: 4708304
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma.
    Barnhill RL; Katzen J; Spatz A; Fine J; Berwick M
    J Cutan Pathol; 2005 Apr; 32(4):268-73. PubMed ID: 15769275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
    Vihinen P; Koskivuo I; Syrjänen K; Tervahartiala T; Sorsa T; Pyrhönen S
    Melanoma Res; 2008 Aug; 18(4):268-73. PubMed ID: 18626311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    van Akkooi AC; de Wilt JH; van Geel AN; Verhoef C; Eggermont AM
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2538; author reply 2538-9. PubMed ID: 16304897
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.
    Weinlich G; Topar G; Eisendle K; Fritsch PO; Zelger B
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):669-77. PubMed ID: 17447982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
    Kruit WH;
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-stage melanoma: staging criteria and prognostic modeling.
    Ross MI
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2312s-2319s. PubMed ID: 16609051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL
    Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U; Buettner PG; Eigentler TK; Garbe C
    J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.